European Committee Provides Positive Opinion on INOVIO’s Application for Orphan Drug Designation for INO-3107
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that the European Committee for Orphan Medicinal Products (COMP) recently provided a positive opinion on INOVIO’s application for orphan drug designation in …
European Committee Provides Positive Opinion on INOVIO’s Application for Orphan Drug Designation for INO-3107 Read More